文献速递糖尿病

出生体重与DD2队列中2型糖尿病诊断后慢性肾脏病风险

Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort.
PubMed 文献 · Diabetologia · 2025-02-01

在DD2队列中,回顾5982例新诊断2型糖尿病患者的助产士记录,低出生体重与慢性肾脏病风险升高相关,10年标准化风险为36.0%对正常出生体重30.6%,风险差5.5%(95%CI -0.5%, 11.8%),调整后HR 1.23(95%CI 0.98, 1.55),但风险估计精确性有限。

要点

  • 低出生体重(<2500 g)者10年慢性肾脏病标准化风险为36.0%,正常出生体重(2500-4000 g)者为30.6%。
  • 低出生体重与慢性肾脏病风险关联的调整后HR为1.23(95%CI 0.98, 1.55),风险差5.5%(95%CI -0.5%, 11.8%)。
  • 出生体重每降低1 kg,尿白蛋白/肌酐比值升高6.6%(95%CI 1.9, 11.1),eGFR无关联。

核心结论

  • 近期诊断2型糖尿病者中,低出生体重史与慢性肾脏病风险升高相关,但风险估计的精确性有限。

研究设计与样本

  • 研究基于丹麦2型糖尿病战略研究中心(DD2)队列2010至2024年间纳入的5982例新诊断2型糖尿病患者,回顾获取原始助产士记录。
  • 随访至首次慢性肾脏病诊断,定义为两次eGFR测量<60 ml/min per 1.73m2或两次尿白蛋白/肌酐比值测量>3 mg/mmol,每次间隔90-365天。
  • 采用Cox回归和样条回归分析计算调整后风险比,所有分析控制性别、入组年龄、出生年份、糖尿病家族史和足月出生状态。
  • 采用混合效应模型分析入组后eGFR和尿白蛋白/肌酐比值的轨迹。

主要发现

  • 共发生1501例慢性肾脏病终点事件,中位随访8.3年,发病率为42.4/1000人年。
  • 以出生体重为连续变量的样条模型显示,调整后慢性肾脏病风险比随出生体重降低而逐渐升高。
  • 低出生体重(<2500 g)者10年标准化慢性肾脏病风险为36.0%,正常出生体重(2500-4000 g)者为30.6%,风险差5.5%(95%CI -0.5%, 11.8%),调整后HR为1.23(95%CI 0.98, 1.55)。
  • 高出生体重(>4000 g)者10年标准化慢性肾脏病风险为33.1%,正常出生体重者为30.6%,风险差2.5%(95%CI -1.6%, 6.7%),调整后HR为1.10(95%CI 0.93, 1.29)。
  • 混合效应模型中,出生体重每降低1 kg,尿白蛋白/肌酐比值升高6.6%(95%CI 1.9, 11.1),eGFR无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出风险估计的精确性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Low birthweight (LBW) is associated with younger age, less obesity and more hypertension among people recently diagnosed with type 2 diabetes, as well as increased cardiovascular morbidity and mortality risk. It is not known whether LBW is associated with an increased risk of incident chronic kidney disease (CKD) among people with a type 2 diabetes diagnosis. METHODS: Original midwife records were retrieved for 5982 participants with recently diagnosed type 2 diabetes enrolled in the Danish Center for Strategic Research in Type 2 Diabetes (DD2) cohort between 2010 and 2024. They were followed until first incident CKD diagnosis, defined as either two eGFR measurements <60 ml/min per 1.73m2 or two urine albumin/creatinine ratio (UACR) measurements >3 mg/mmol, each 90-365 days apart. Confounder-standardised 10 year risks of CKD were estimated, with death considered as a competing risk. Adjusted hazard ratios (aHRs) for CKD were computed using Cox and spline regression analyses. All analyses were controlled for differences in sex, age at enrolment, calendar year at birth, family history of diabetes and born-at-term status. Mixed-effects models were used to examine the trajectories of eGFR and UACR following enrolment. RESULTS: A total of 1501 incident CKD endpoints occurred, corresponding to an incidence rate of 42.4 per 1000 person-years over a median follow-up time of 8.3 years. Spline models with birthweight as a continuous measure showed progressively increasing aHRs for CKD with decreasing birthweight. The 10-year standardised risk of CKD was 36.0% in people with LBW (<2500 g) and 30.6% in people with a normal birthweight (2500-4000 g), yielding a risk difference (RD) of 5.5% (95% CI -0.5%, 11.8%) and an aHR of 1.23 (95% CI 0.98, 1.55). People with type 2 diabetes and high birthweight (>4000 g) had a similar 10-year standardised CKD risk compared with normal birthweight (33.1% and 30.6%, respectively). This yielded an RD of 2.5% (95% CI -1.6%, 6.7%) and an aHR of 1.10 (95% CI 0.93, 1.29). In mixed-effects models examining eGFR and UACR trajectories, each 1 kg decrease in birthweight was associated with a 6.6% (95% CI 1.9, 11.1) increase in UACR, whereas no association was found for eGFR. CONCLUSIONS/INTERPRETATION: A history of LBW was associated with elevated risk of CKD among people with a recent type 2 diabetes diagnosis, although the precision of risk estimates was limited.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hansen AL, Christiansen CF, Brøns C, et al. Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort. Diabetologia. 2025. PMID: 39891704. doi:10.1007/s00125-024-06357-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。